About Aphios
Aphios is a company based in Boston (United States) founded in 1993.. Aphios offers products and services including Zindol, APH-0701, nanoHYP, and Xantol. Aphios operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Biogen, among others.
- Headquarter Boston, United States
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Aphios Pharma Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$504.73 K (USD), Grant
Sep 25, 2024
-
Investors
Citizens Bank
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aphios
Aphios offers a comprehensive portfolio of products and services, including Zindol, APH-0701, nanoHYP, and Xantol. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Oncology treatment using nanotechnology for cancer management.
Oncology-focused drug in development pipeline.
Infectious disease treatment targeting HIV and influenza.
CNS disorder therapy for conditions like Alzheimer's.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Aphios
- Total Funding Total Funding
- Total Rounds 18
- Last Round Grant — $504,732
-
First Round
First Round
(22 Apr 2008)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Grant - Aphios | Valuation |
investors |
|
| Sep, 2023 | Amount | Grant - Aphios | Valuation |
investors |
|
| Jul, 2023 | Amount | Grant - Aphios | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Aphios
Aphios has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include Citizens Bank, NIH and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Federal innovation and scientific achievement services are provided.
|
Founded Year | Domain | Location | |
|
Commercial banking services are provided to individuals and businesses.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Aphios
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Aphios
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aphios Comparisons
Competitors of Aphios
Aphios operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Biogen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Aphios
Frequently Asked Questions about Aphios
When was Aphios founded?
Aphios was founded in 1993 and raised its 1st funding round 15 years after it was founded.
Where is Aphios located?
Aphios is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
What does Aphios do?
Founded in 1993 and based in Boston, United States, therapeutics are developed by the company for cancer treatment, supportive care, infectious diseases including HIV, influenza, and coronavirus, as well as central and peripheral nervous system disorders such as Alzheimers disease, multiple sclerosis, pain, and addiction. Operations focus on pharmaceutical innovation in the biotechnology sector. The lead compound, Zindol, an enhanced ginger product, targets chemotherapy-induced nausea and vomiting.
Who are the top competitors of Aphios?
Aphios's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
What products or services does Aphios offer?
Aphios offers Zindol, APH-0701, nanoHYP, and Xantol.
Who are Aphios's investors?
Aphios has 5 investors. Key investors include Citizens Bank, NIH, HHS, SBIR, and National Heart, Lung, and Blood Institute.